X
XLinkedinWhatsAppTelegramTelegram
0
1

Elanco: The European Commission Authorises the Marketing of Prevtec Microbia’s Coliprotec® F4

Coliprotec® F4 will be distributed in the European Union by Elanco Animal Health (Elanco), a major player in the animal health industry doing business in more than 75 countries.

24 March 2015
X
XLinkedinWhatsAppTelegramTelegram
0
1

elanco.gifprevtec.jpgPrevtec Microbia Inc. announces that its German subsidiary, Prevtec Microbia GmbH, received marketing authorisation for its vaccine, Coliprotec® F4, in the European Union, an important market for the Canadian company.

Coliprotec® F4 will be distributed in the European Union by Elanco Animal Health (Elanco), a major player in the animal health industry doing business in more than 75 countries.

Coliprotec® F4 is a live oral vaccine that will enable European veterinarians and producers to access a new technology for immunizing piglets against enterotoxigenic F4-positive E. coli, which is associated with post-weaning diarrhea (PWD).

“We are very happy to have received the European Commission’s approval for Coliprotec® F4. We believe our product will be very successful, not only because it’s a pioneering alternative to the existing solutions but because we can also count on Elanco’s exceptional team,” said Michel Fortin, President and CEO of Prevtec Microbia Inc.

“We are proud to offer this new option to European veterinarians and producers. With its single dose and practical oral administration that follows the natural route of infection, Coliprotec® F4 will be an important tool for fighting against E. coli infections in swine. Such an achievement was possible thanks to the contribution of German CRO, Klifovet AG and Spanish CMO, CZ Veterinaria S.A.,’’ stated Dr. Eric Nadeau, VP Scientific Affairs at Prevtec Microbia Inc.

"As a major breakthrough in the fight against post-weaning diarrhea in pigs, Coliprotec® F4 is a significant addition to our range of vaccines. We see this as a further opportunity to deliver innovation and value to our customers” said Ramiro Cabral, Head of Elanco Operations for Europe, Middle East and Africa .

Developed by Prevtec Microbia, Coliprotec® F4 has been available in the Canadian market for over seven years.

March 24, 2015 - Elanco

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list Swine News

Swine industry news in your email

Log in and sign up on the list

Welcome to 333

Connect, share, and interact with the largest community of professionals in the swine industry.

Celebrating 155846Users on 333!

Sign upAlready a member?
Recommended accounts
Zhou  Lydia

Zhou Lydia

Other - China
DAVI  LIOU

DAVI LIOU

Other - China
Kemin

Kemin

Company - Belgium
ECO Animal Health
Company - United Kingdom
Boehringer Ingelheim Vetmedica GmbH
Company - Germany